Exchange Traded Concepts LLC Reduces Position in Agilent Technologies, Inc. (NYSE:A)

Exchange Traded Concepts LLC cut its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 47.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,405 shares of the medical research company’s stock after selling 10,469 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Agilent Technologies were worth $1,693,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the business. Western Pacific Wealth Management LP lifted its holdings in Agilent Technologies by 18.9% during the first quarter. Western Pacific Wealth Management LP now owns 440 shares of the medical research company’s stock valued at $64,000 after purchasing an additional 70 shares during the last quarter. Ballentine Partners LLC increased its position in shares of Agilent Technologies by 2.5% during the first quarter. Ballentine Partners LLC now owns 2,963 shares of the medical research company’s stock valued at $431,000 after buying an additional 73 shares during the period. Haverford Trust Co increased its position in shares of Agilent Technologies by 1.7% during the first quarter. Haverford Trust Co now owns 4,423 shares of the medical research company’s stock valued at $644,000 after buying an additional 74 shares during the period. Menard Financial Group LLC increased its position in shares of Agilent Technologies by 1.6% during the second quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company’s stock valued at $628,000 after buying an additional 77 shares during the period. Finally, Salem Investment Counselors Inc. increased its position in shares of Agilent Technologies by 4.4% during the first quarter. Salem Investment Counselors Inc. now owns 2,259 shares of the medical research company’s stock valued at $329,000 after buying an additional 95 shares during the period. 87.42% of the stock is owned by hedge funds and other institutional investors.

Agilent Technologies Price Performance

A opened at $144.58 on Wednesday. The stock has a 50-day moving average price of $140.87 and a 200-day moving average price of $138.86. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $155.35. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $42.18 billion, a P/E ratio of 34.18, a PEG ratio of 6.96 and a beta of 1.05.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.06. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. Agilent Technologies’s quarterly revenue was down 5.6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.43 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be paid a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a dividend yield of 0.65%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on A. UBS Group upped their price target on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Stifel Nicolaus reiterated a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. Citigroup upped their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Evercore ISI lifted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Finally, TD Cowen increased their price target on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $144.36.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,953 shares of company stock valued at $2,013,630. Insiders own 0.33% of the company’s stock.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.